The DOI matches its Crossref record; 315 of the 315 references it cites were found in a registry or an index.
Emerging Prospects of Exosomes for Cancer Treatment: From Conventional Therapy to Immunotherapy
Open accessAbstract
Exosomes are a class of extracellular vesicles of around 100 nm in diameter that are secreted by most cells and contain various bioactive molecules reflecting their cellular origin and mediate intercellular communication. Studies of these exosomal features in tumor pathogenesis have led to the development of therapeutic and diagnostic approaches using exosomes for cancer therapy. Exosomes have many advantages for conveying therapeutic agents such as small interfering RNAs, microRNAs, membrane‐associated proteins, and chemotherapeutic compounds; thus, they are considered a prime candidate as a delivery tool for cancer treatment. Since exosomes also provide an optimal microenvironment for the effective function of immunomodulatory factors, exosomes harboring bioactive molecules have been bioengineered as cancer immunotherapies that can effectively activate each stage of the cancer immunity cycle to successfully elicit cancer‐specific immunity. This review discusses the advantages of exosomes for treating cancer and the challenges that must be overcome for their successful clinical development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–315 of 315
Abd Elmageed, Z. Y., Yang, Y., Thomas, R., Ranjan, M., Mondal, D., Moroz, K., Fang, Z., Rezk, B. M., Moparty, K., Sikka, S. C., et al. (2014) · Stem Cells · doi:10.1002/stem.1619 · Cited by 295
Hyaluronan in human malignancies
Sironen, R. K., Tammi, M., Tammi, R., Auvinen, P. K., Anttila, M., & Kosma, V.-M. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.11.017 · Cited by 294
Bioluminescence imaging: progress and applications
Badr, C. E., & Tannous, B. A. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2011.06.010 · Cited by 292
Ding, G., Zhou, L., Qian, Y., Fu, M., Chen, J., Chen, J., Xiang, J., Wu, Z., Jiang, G., & Cao, L. (2015) · Oncotarget · doi:10.18632/oncotarget.4924 · Cited by 285
Morishita, M., Takahashi, Y., Nishikawa, M., Sano, K., Kato, K., Yamashita, T., Imai, T., Saji, H., & Takakura, Y. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24251 · Cited by 285
Plebanek, M. P., Angeloni, N. L., Vinokour, E., Li, J., Henkin, A., Martinez-Marin, D., Filleur, S., Bhowmick, R., Henkin, J., Miller, S. D., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01433-3 · Cited by 285
Reprogramming Exosomes as Nanoscale Controllers of Cellular Immunity
Cheng, Q., Shi, X., Han, M., Smbatyan, G., Lenz, H.-J., & Zhang, Y. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b10047 · Cited by 285
Exosomes Increase the Therapeutic Index of Doxorubicin in Breast and Ovarian Cancer Mouse Models
Hadla, M., Palazzolo, S., Corona, G., Caligiuri, I., Canzonieri, V., Toffoli, G., & Rizzolio, F. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0154 · Cited by 282
Charoenviriyakul, C., Takahashi, Y., Morishita, M., Matsumoto, A., Nishikawa, M., & Takakura, Y. (2017) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.10.009 · Cited by 280
Rapid magnetic isolation of extracellular vesicles via lipid-based nanoprobes
Wan, Y., Cheng, G., Liu, X., Hao, S.-J., Nisic, M., Zhu, C.-D., Xia, Y.-Q., Li, W.-Q., Wang, Z.-G., Zhang, W.-L., et al. (2017) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0058 · Cited by 279
Schuler, P. J., Saze, Z., Hong, C.-S., Muller, L., Gillespie, D. G., Cheng, D., Harasymczuk, M., Mandapathil, M., Lang, S., Jackson, E. K., et al. (2014) · Clinical and Experimental Immunology · doi:10.1111/cei.12354 · Cited by 277
Garg, A. D., & Agostinis, P. (2014) · Photochemical & Photobiological Sciences · doi:10.1039/c3pp50333j · Cited by 276
O’Brien, K., Lowry, M. C., Corcoran, C., Martinez, V. G., Daly, M., Rani, S., Gallagher, W. M., Radomski, M. W., MacLeod, R. A. F., & O’Driscoll, L. (2015) · Oncotarget · doi:10.18632/oncotarget.5192 · Cited by 273
The Origin and Functions of Exosomes in Cancer
Rajagopal, C., & Harikumar, K. B. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00066 · Cited by 271
Exosomal formulation enhances therapeutic response of celastrol against lung cancer
Aqil, F., Kausar, H., Agrawal, A. K., Jeyabalan, J., Kyakulaga, A.-H., Munagala, R., & Gupta, R. (2016) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2016.05.013 · Cited by 268
Immune Suppression in the Tumor Microenvironment
Gajewski, T. F., Meng, Y., & Harlin, H. (2006) · Journal of Immunotherapy · doi:10.1097/01.cji.0000199193.29048.56 · Cited by 265
Montecalvo, A., Shufesky, W. J., Beer Stolz, D., Sullivan, M. G., Wang, Z., Divito, S. J., Papworth, G. D., Watkins, S. C., Robbins, P. D., Larregina, A. T., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3081 · Cited by 265
Making Better Chimeric Antigen Receptors for Adoptive T-cell Therapy
Maus, M. V., & June, C. H. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1433 · Cited by 265
Li, Z., Wang, H., Yin, H., Bennett, C., Zhang, H.-G., & Guo, P. (2018) · Scientific Reports · doi:10.1038/s41598-018-32953-7 · Cited by 260
Exosome-Like Vesicles with Dipeptidyl Peptidase IV in Human Saliva
Ogawa, Y., Kanai-Azuma, M., Akimoto, Y., Kawakami, H., & Yanoshita, R. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.1059 · Cited by 258
Extracellular vesicles as a platform for membrane‐associated therapeutic protein delivery
Yang, Y., Hong, Y., Cho, E., Kim, G. B., & Kim, I. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1440131 · Cited by 258
Self-citationArntz, O. J., Pieters, B. C. H., Oliveira, M. C., Broeren, M. G. A., Bennink, M. B., de Vries, M., van Lent, P. L. E. M., Koenders, M. I., van den Berg, W. B., van der Kraan, P. M., et al. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500222 · Cited by 255
Wiklander, O. P. B., Bostancioglu, R. B., Welsh, J. A., Zickler, A. M., Murke, F., Corso, G., Felldin, U., Hagey, D. W., Evertsson, B., Liang, X.-M., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01326 · Cited by 252
Melzer, C., Rehn, V., Yang, Y., Bähre, H., von der Ohe, J., & Hass, R. (2019) · Cancers · doi:10.3390/cancers11060798 · Cited by 245
A unique tumor antigen produced by a single amino acid substitution
Monach, P. A., Meredith, S. C., T.Siegel, C., & Schreiber, H. (1995) · Immunity · doi:10.1016/1074-7613(95)90078-0 · Cited by 241
Lang, F. M., Hossain, A., Gumin, J., Momin, E. N., Shimizu, Y., Ledbetter, D., Shahar, T., Yamashita, S., Parker Kerrigan, B., Fueyo, J., et al. (2018) · Neuro-Oncology · doi:10.1093/neuonc/nox152 · Cited by 239
Knuth, A., Danowski, B., Oettgen, H. F., & Old, L. J. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.11.3511 · Cited by 236
Tumor exosomes block dendritic cells maturation to decrease the T cell immune response
Ning, Y., Shen, K., Wu, Q., Sun, X., Bai, Y., Xie, Y., Pan, J., & Qi, C. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.05.002 · Cited by 235
Behavioral intervention for cancer treatment side effects
Redd, W. H., Montgomery, G. H., & DuHamel, K. N. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.11.810 · Cited by 231
Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer Immunotherapy
Shi, X., Cheng, Q., Hou, T., Han, M., Smbatyan, G., Lang, J. E., Epstein, A. L., Lenz, H.-J., & Zhang, Y. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2019.11.020 · Cited by 231
Zhou, J., Dudley, M. E., Rosenberg, S. A., & Robbins, P. F. (2005) · Journal of Immunotherapy · doi:10.1097/00002371-200501000-00007 · Cited by 225
Iwai, K., Minamisawa, T., Suga, K., Yajima, Y., & Shiba, K. (2016) · Journal of Extracellular Vesicles · doi:10.3402/jev.v5.30829 · Cited by 225
Exosomal formulation of anthocyanidins against multiple cancer types
Munagala, R., Aqil, F., Jeyabalan, J., Agrawal, A. K., Mudd, A. M., Kyakulaga, A. H., Singh, I. P., Vadhanam, M. V., & Gupta, R. C. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.02.004 · Cited by 224
Subcellular Fate and Off-Target Effects of siRNA, shRNA, and miRNA
Singh, S., Narang, A. S., & Mahato, R. I. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0608-1 · Cited by 220
CAR T-cell therapy for B-cell lymphomas: clinical trial results of available products
Chavez, J. C., Bachmeier, C., & Kharfan-Dabaja, M. A. (2019) · Therapeutic Advances in Hematology · doi:10.1177/2040620719841581 · Cited by 220
Elward, K. (2003) · Molecular Immunology · doi:10.1016/s0161-5890(03)00109-3 · Cited by 219
T-lymphocyte homing: an underappreciated yet critical hurdle for successful cancer immunotherapy
Sackstein, R., Schatton, T., & Barthel, S. R. (2017) · Laboratory Investigation · doi:10.1038/labinvest.2017.25 · Cited by 215
Im, E.-J., Lee, C.-H., Moon, P.-G., Rangaswamy, G. G., Lee, B., Lee, J. M., Lee, J.-C., Jee, J.-G., Bae, J.-S., Kwon, T.-K., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09387-4 · Cited by 208
Human interferon lambda-1 (IFN-λ1/IL-29) modulates the Th1/Th2 response
Jordan, W. J., Eskdale, J., Srinivas, S., Pekarek, V, Kelner, D., Rodia, M., & Gallagher, G. (2007) · Genes & Immunity · doi:10.1038/sj.gene.6364382 · Cited by 206
Yang, T., Fogarty, B., LaForge, B., Aziz, S., Pham, T., Lai, L., & Bai, S. (2017) · The AAPS Journal · doi:10.1208/s12248-016-0015-y · Cited by 204
Dendritic Cell–Derived Exosomes Need To Activate Both T and B Cells To Induce Antitumor Immunity
Näslund, T. I., Gehrmann, U., Qazi, K. R., Karlsson, M. C. I., & Gabrielsson, S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203082 · Cited by 203
Tying It All Together: Epigenetics, Genetics, Cell Cycle, and Cancer
Baylin, S. B. (1997) · Science · doi:10.1126/science.277.5334.1948 · Cited by 202
Ohkuri, T., Kosaka, A., Ishibashi, K., Kumai, T., Hirata, Y., Ohara, K., Nagato, T., Oikawa, K., Aoki, N., Harabuchi, Y., et al. (2017) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-017-1975-1 · Cited by 201
Corrales, L., & Gajewski, T. F. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1362 · Cited by 197
Increasing vaccine potency through exosome antigen targeting
Hartman, Z. C., Wei, J., Glass, O. K., Guo, H., Lei, G., Yang, X.-Y., Osada, T., Hobeika, A., Delcayre, A., Le Pecq, J.-B., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.09.133 · Cited by 196
Wang, Y., Chen, X., Tian, B., Liu, J., Yang, L., Zeng, L., Chen, T., Hong, A., & Wang, X. (2017) · Theranostics · doi:10.7150/thno.16532 · Cited by 196
Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy
Lupo, K. B., & Matosevic, S. (2019) · Cancers · doi:10.3390/cancers11060769 · Cited by 196
Enhancing Efficacy of Anticancer Vaccines by Targeted Delivery to Tumor-Draining Lymph Nodes
Jeanbart, L., Ballester, M., de Titta, A., Corthésy, P., Romero, P., Hubbell, J. A., & Swartz, M. A. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0019-t · Cited by 191
Delivery and Specificity of CRISPR/Cas9 Genome Editing Technologies for Human Gene Therapy
Gori, J. L., Hsu, P. D., Maeder, M. L., Shen, S., Welstead, G. G., & Bumcrot, D. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.074 · Cited by 189
The Potential of Exosomes From Cow Milk for Oral Delivery
Betker, J. L., Angle, B. M., Graner, M. W., & Anchordoquy, T. J. (2019) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.11.022 · Cited by 189
Nanosomes carrying doxorubicin exhibit potent anticancer activity against human lung cancer cells
Srivastava, A., Amreddy, N., Babu, A., Panneerselvam, J., Mehta, M., Muralidharan, R., Chen, A., Zhao, Y. D., Razaq, M., Riedinger, N., et al. (2016) · Scientific Reports · doi:10.1038/srep38541 · Cited by 187
Exosomes as Drug Carriers for Cancer Therapy
Pullan, J. E., Confeld, M. I., Osborn, J. K., Kim, J., Sarkar, K., & Mallik, S. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00104 · Cited by 181
Capello, M., Vykoukal, J. V., Katayama, H., Bantis, L. E., Wang, H., Kundnani, D. L., Aguilar-Bonavides, C., Aguilar, M., Tripathi, S. C., Dhillon, D. S., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08109-6 · Cited by 179
Perets, N., Hertz, S., London, M., & Offen, D. (2018) · Molecular Autism · doi:10.1186/s13229-018-0240-6 · Cited by 171
Human γδ T Cells: A Lymphoid Lineage Cell Capable of Professional Phagocytosis
Wu, Y., Wu, W., Wong, W. M., Ward, E., Thrasher, A. J., Goldblatt, D., Osman, M., Digard, P., Canaday, D. H., & Gustafsson, K. T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901772 · Cited by 167
Genomics of response to immune checkpoint therapies for cancer: implications for precision medicine
Conway, J. R., Kofman, E., Mo, S. S., Elmarakeby, H., & Van Allen, E. (2018) · Genome Medicine · doi:10.1186/s13073-018-0605-7 · Cited by 165
Chang, A. E., Aruga, A., Cameron, M. J., Sondak, V. K., Normolle, D. P., Fox, B. A., & Shu, S. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.2.796 · Cited by 165
Intrinsic Resistance of Solid Tumors to Immune Checkpoint Blockade Therapy
Zhao, X., & Subramanian, S. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2379 · Cited by 162
Williams, A. M., Dennahy, I. S., Bhatti, U. F., Halaweish, I. F., Xiong, Y., Chang, P., Nikolian, V. C., Chtraklin, K., Brown, J. F., Zhang, Y., et al. (2018) · Journal of Neurotrauma · doi:10.1089/neu.2018.5711 · Cited by 162
The Cancer Immunotherapy Revolution
Kelly, P. N. (2018) · Science · doi:10.1126/science.359.6382.1344 · Cited by 159
Exosomal Doxorubicin Reduces the Cardiac Toxicity of Doxorubicin
Toffoli, G., Hadla, M., Corona, G., Caligiuri, I., Palazzolo, S., Semeraro, S., Gamini, A., Canzonieri, V., & Rizzolio, F. (2015) · Nanomedicine · doi:10.2217/nnm.15.118 · Cited by 156
The emergent role of exosomes in glioma
Gourlay, J., Morokoff, A. P., Luwor, R. B., Zhu, H., Kaye, A. H., & Stylli, S. S. (2016) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2016.09.021 · Cited by 155
Yang, Y., Hong, Y., Nam, G., Chung, J. H., Koh, E., & Kim, I. (2017) · Advanced Materials · doi:10.1002/adma.201605604 · Cited by 154
Self-citationExosome Determinants of Physiological Aging and Age-Related Neurodegenerative Diseases
D’Anca, M., Fenoglio, C., Serpente, M., Arosio, B., Cesari, M., Scarpini, E. A., & Galimberti, D. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00232 · Cited by 154
Wahlund, C. J. E., Akpinar, G. G., Hiltbrunner, S., Veerman, R. E., Näslund, T. I., & Gabrielsson, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-16609-6 · Cited by 153
Romagnoli, G. G., Zelante, B. B., Toniolo, P. A., Migliori, I. K., & Barbuto, J. A. M. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00692 · Cited by 152
pH-responsive hyaluronate-anchored extracellular vesicles to promote tumor-targeted drug delivery
Lee, H., Park, H., Noh, G. J., & Lee, E. S. (2018) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.08.141 · Cited by 152
Garg, A. D., Romano, E., Rufo, N., & Agostinis, P. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.5 · Cited by 151
Li, H., Yang, C., Shi, Y., & Zhao, L. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0429-z · Cited by 150
cGAS‐cGAMP‐STING: The three musketeers of cytosolic DNA sensing and signaling
Tao, J., Zhou, X., & Jiang, Z. (2016) · IUBMB Life · doi:10.1002/iub.1566 · Cited by 146
Failure of cancer vaccines: the significant limitations of this approach to immunotherapy.
Bödey, B., Bodey, B., Siegel, S. E., & Kaiser, H. E. (2000) · PubMed · Cited by 143
Dubey, P., Hendrickson, R. C., Meredith, S. C., Siegel, C., Shabanowitz, J., Skipper, J., Engelhard, V. H., Hunt, D. F., & Schreiber, H. W. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.4.695 · Cited by 143
Montermini, L., Meehan, B., Garnier, D., Lee, W. J., Lee, T. H., Guha, A., Al-Nedawi, K. N. I., & Rak, J. W. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.679217 · Cited by 142
Regulatory T Cell and Forkhead Box Protein 3 as Modulators of Immune Homeostasis
Pereira, L. M. S., Gomes, S. T. M., Ishak, R., & Vallinoto, A. C. R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00605 · Cited by 137
Microbiota-Derived Extracellular Vesicles as New Systemic Regulators
Badi, S. A., Moshiri, A., Fateh, A., Jamnani, F. R., Sarshar, M., Vaziri, F., & Siadat, S. D. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01610 · Cited by 136
A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.
van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., Plaen, E. D., den Eynde, B. J. V., Knuth, A. K., & Boon, T. (2007) · PubMed · Cited by 133
Shoae‐Hassani, A., Hamidieh, A. A., Behfar, M., Mohseni, R., Mortazavi‐Tabatabaei, S. A., & Asgharzadeh, S. (2017) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000179 · Cited by 133
Hong, Y., Nam, G., Koh, E., Jeon, S., Kim, G. B., Jeong, C., Kim, D. H., Yang, Y., & Kim, I.-S. (2017) · Advanced Functional Materials · doi:10.1002/adfm.201703074 · Cited by 130
Self-citationGomzikova, M. O., James, V. H., & Rizvanov, A. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02663 · Cited by 128
Monfared, H., Jahangard, Y., Nikkhah, M., Mirnajafi-Zadeh, J., & Mowla, S. J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00782 · Cited by 123
Nam, G., Lee, E. J., Kim, Y. K., Hong, Y., Choi, Y., Ryu, M., Woo, J., Cho, Y., Ahn, D. J., Yang, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04607-9 · Cited by 117
Self-citationStefanius, K., Servage, K. A., Santos, M. D. S., Gray, H. F., Toombs, J. E., Chimalapati, S., Kim, M. S., Malladi, V. S., Brekken, R. A., & Orth, K. (2019) · eLife · doi:10.7554/elife.40226 · Cited by 117
Cho, E., Nam, G., Hong, Y., Kim, Y. K., Kim, D., Yang, Y., & Kim, I. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.04.037 · Cited by 116
Self-citationGlioma-derived extracellular vesicles selectively suppress immune responses
Hellwinkel, J. E., Redzic, J. S., Harland, T., Gunaydin, D., Anchordoquy, T. J., & Graner, M. W. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov170 · Cited by 115
Zhou, J., Tan, X., Tan, Y., Li, Q., Ma, J., & Wang, G. (2018) · Journal of Cancer · doi:10.7150/jca.25376 · Cited by 113
Chang, A. E., Li, Q., Jiang, G., Sayre, D. M., Braun, T., & Redman, B. G. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.023 · Cited by 109
Development and regulation of exosome‐based therapy products
Batrakova, E. V., & Kim, M. S. (2016) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1395 · Cited by 101
Garofalo, M., Villa, A. M., Rizzi, N., Kuryk, Ł., Mazzaferro, V., & Ciana, P. (2018) · Viruses · doi:10.3390/v10100558 · Cited by 101
Biomaterials as vectors for the delivery of CRISPR–Cas9
Eoh, J. H., & Gu, L. (2019) · Biomaterials Science · doi:10.1039/c8bm01310a · Cited by 97
Pathogen recognition receptors, cancer and inflammation in the gut
Fukata, M., & Abreu, M. T. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.09.006 · Cited by 94
Mechanisms of Intrinsic Tumor Resistance to Immunotherapy
Rieth, J. M., & Subramanian, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051340 · Cited by 93
Garg, A. D., Elsen, S., Krysko, D. V., Vandenabeele, P., de Witte, P., & Agostinis, P. (2015) · Oncotarget · doi:10.18632/oncotarget.4754 · Cited by 87
Paclitaxel chemotherapy: from empiricism to a mechanism-based formulation strategy
Scripture, C. D., Figg, W. D., & Sparreboom, A. (2005) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.1.2.107.62910 · Cited by 86
Exosomes: Biogenesis, Composition, Functions, and Their Role in Pre-metastatic Niche Formation
Patil, A. A., & Rhee, W. J. (2019) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-019-0170-y · Cited by 82
Harnessing NK Cells for Cancer Treatment
Minetto, P., Guolo, F., Pesce, S., Greppi, M., Obino, V., Ferretti, E., Sivori, S., Genova, C., Lemoli, R., & Marcenaro, E. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02836 · Cited by 81
Wang, J., Wang, L., Lin, Z., Tao, L., & Chen, M. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1759 · Cited by 77
Hosoi, A., Takeda, K., Nagaoka, K., Iino, T., Matsushita, H., Ueha, S., Aoki, S., Matsushima, K., Kubo, M., Morikawa, T., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19548-y · Cited by 73
The inducers of immunogenic cell death for tumor immunotherapy
Li, X. (2017) · Tumori Journal · doi:10.5301/tj.5000675 · Cited by 71
Hong, Y., Kim, Y. K., Kim, G. B., Nam, G., Kim, S. A., Park, Y., Yang, Y., & Kim, I. (2019) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2019.1670893 · Cited by 71
Self-citationHong, Y., Nam, G., Koh, E., Jeon, S., Kim, G. B., Jeong, C., Kim, D., Yang, Y., & Kim, I. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201801301 · Cited by 69
Self-citationMesenchymal Stem Cells in Cardiology
White, I. A., Sanina, C., Balkan, W., & Hare, J. M. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3584-0_4 · Cited by 68
Kim, G. B., Nam, G., Hong, Y., Woo, J., Cho, Y., Kwon, I. C., Yang, Y., & Kim, I. (2020) · Science Advances · doi:10.1126/sciadv.aaz2083 · Cited by 68
Self-citationSohl, S. J., Schnur, J. B., & Montgomery, G. H. (2009) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2009.01.008 · Cited by 67
Combined ipilimumab and nivolumab first‐line and after BRAF‐targeted therapy in advanced melanoma
Mason, R., Dearden, H. C., Nguyen, B., Soon, J. A., Smith, J. L., Randhawa, M., Mant, A. M., Warburton, L., Lo, S., Meniawy, T. M., et al. (2019) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12831 · Cited by 60
Delivery systems of CRISPR/Cas9-based cancer gene therapy
Biagioni, A., Laurenzana, A., Margheri, F., Chillà, A., Fibbi, G., & Rosso, M. D. (2018) · Journal of Biological Engineering · doi:10.1186/s13036-018-0127-2 · Cited by 57
Statin-induced GGPP depletion blocks macropinocytosis and starves cells with oncogenic defects
Jiao, Z., Cai, H., Yu, L., Sirka, O. K., Padmanaban, V., Ewald, A. J., & Devreotes, P. N. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1917938117 · Cited by 52
Kotmakçı, M., & Çetintaş, V. B. (2015) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j36w3x · Cited by 51
Targeting CD8 + T-cell Tolerance for Cancer Immunotherapy
Jackson, S. R., Yuan, J., & Teague, R. M. (2014) · Immunotherapy · doi:10.2217/imt.14.51 · Cited by 48
Ikeda, Y., Kiyotani, K., Yew, P. Y., Sato, S., Imai, Y., Yamaguchi, R., Miyano, S., Fujiwara, K., Hasegawa, K., & Nakamura, Y. (2017) · Oncology Reports · doi:10.3892/or.2017.5536 · Cited by 45
Yang, Y., Nam, G., Kim, G. B., Kim, Y. K., & Kim, I. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.05.007 · Cited by 40
Self-citationToward Exosome-Based Neuronal Diagnostic Devices
Yoo, Y. K., Lee, J., Kim, H., Hwang, K., Yoon, D., & Lee, J. H. (2018) · Micromachines · doi:10.3390/mi9120634 · Cited by 27
Harnessing immune checkpoints in myeloid lineage cells for cancer immunotherapy
Park, S., & Kim, I. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.03.018 · Cited by 24
Self-citationComplex adaptive therapeutic strategy (CATS) for cancer
Cho, Y. W., Kim, S. Y., Kwon, I. C., & Kim, I.-S. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.12.017 · Cited by 20
Self-citationGlickman, L. H., Kanne, D. B., Kasibhatla, S., Li, J., Pferdekamper, A. C., Gauthier, K. E. S., Deng, W., Desbien, A. L., Katibah, G. E., Leong, J. J., et al. (2016) · Cancer Research · doi:10.1158/1538-7445.am2016-1445 · Cited by 11
Koga (2011) · doi:10.3978/j.issn.2078-6891.2011.015
Cited by
Clinical applications of stem cell-derived exosomes
Tan, F., Li, X., Wang, Z., Li, J., Shahzad, K., & Zheng, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01704-0 · Cited by 708
Exosome Processing and Characterization Approaches for Research and Technology Development
Lai, J. J., Chau, Z. L., Chen, S., Hill, J. J., Korpany, K. V., Liang, N., Lin, L., Lin, Y., Liu, J. K., Liu, Y., et al. (2022) · Advanced Science · doi:10.1002/advs.202103222 · Cited by 623
Mesenchymal stem/stromal cells in cancer therapy
Lan, T., Luo, M., & Wei, X. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01208-w · Cited by 374
Engineered neutrophil-derived exosome-like vesicles for targeted cancer therapy
Zhang, J., Ji, C., Zhang, H., Shi, H., Mao, F., Qian, H., Xu, W., Wang, D., Pan, J., Fang, X., et al. (2022) · Science Advances · doi:10.1126/sciadv.abj8207 · Cited by 265
Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery
Waheed, S., Li, Z., Zhang, F., Chiarini, A., Armato, U., & Wu, J. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01605-4 · Cited by 259
Metadata
- Authors
- Nam, G., Choi, Y., Kim, G. B., Kim, S., Kim, S. A., & Kim, I.
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2020-10-05
- Volume
- 32
- Issue
- 51
- Pages
- e2002440-e2002440
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W3091590487
- Cited by
- 267
- References
- 315
- FWCI
- 11.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.